Publication:
Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection

dc.contributor.authorUtpala Nanda Chowdhuryen_US
dc.contributor.authorMd Omar Faruqeen_US
dc.contributor.authorMd Mehedyen_US
dc.contributor.authorShamim Ahmaden_US
dc.contributor.authorM. Babul Islamen_US
dc.contributor.authorWatshara Shoombuatongen_US
dc.contributor.authorA. K.M. Azaden_US
dc.contributor.authorMohammad Ali Monien_US
dc.contributor.otherThe University of Queenslanden_US
dc.contributor.otherUniversity of Technology Sydneyen_US
dc.contributor.otherRajshahi Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2022-08-04T08:25:51Z
dc.date.available2022-08-04T08:25:51Z
dc.date.issued2021-11-01en_US
dc.description.abstractThe coronavirus disease 2019 (COVID-19) is caused by the infection of highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as the novel coronavirus. In most countries, the containment of this virus spread is not controlled, which is driving the pandemic towards a more difficult phase. In this study, we investigated the impact of the Bacille Calmette Guerin (BCG) vaccination on the severity and mortality of COVID-19 by performing transcriptomic analyses of SARS-CoV-2 infected and BCG vaccinated samples in peripheral blood mononuclear cells (PBMC). A set of common differentially expressed genes (DEGs) were identified and seeded into their functional enrichment analyses via Gene Ontology (GO)-based functional terms and pre-annotated molecular pathways databases, and their Protein-Protein Interaction (PPI) network analysis. We further analysed the regulatory elements, possible comorbidities and putative drug candidates for COVID-19 patients who have not been BCG-vaccinated. Differential expression analyses of both BCG-vaccinated and COVID-19 infected samples identified 62 shared DEGs indicating their discordant expression pattern in their respected conditions compared to control. Next, PPI analysis of those DEGs revealed 10 hub genes, namely ITGB2, CXCL8, CXCL1, CCR2, IFNG, CCL4, PTGS2, ADORA3, TLR5 and CD33. Functional enrichment analyses found significantly enriched pathways/GO terms including cytokine activities, lysosome, IL-17 signalling pathway, TNF-signalling pathways. Moreover, a set of identified TFs, miRNAs and potential drug molecules were further investigated to assess their biological involvements in COVID-19 and their therapeutic possibilities. Findings showed significant genetic interactions between BCG vaccination and SARS-CoV-2 infection, suggesting an interesting prospect of the BCG vaccine in relation to the COVID-19 pandemic. We hope it may potentially trigger further research on this critical phenomenon to combat COVID-19 spread.en_US
dc.identifier.citationComputers in Biology and Medicine. Vol.138, (2021)en_US
dc.identifier.doi10.1016/j.compbiomed.2021.104891en_US
dc.identifier.issn18790534en_US
dc.identifier.issn00104825en_US
dc.identifier.other2-s2.0-85116410875en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/76629
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85116410875&origin=inwarden_US
dc.subjectComputer Scienceen_US
dc.subjectMedicineen_US
dc.titleEffects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infectionen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85116410875&origin=inwarden_US

Files

Collections